Search Results 441-450 of 11594 for Impetigo

  1. Infectious Diseases - Clinical trials

    Learn about the expertise and services, including travel medicine, offered at Mayo Clinic to people with concerns about infectious diseases.

  2. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

  3. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  4. A Study Of PY314 In Subjects With Advanced Solid Tumors - Mayo Clinic

    About this study. A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and ...

  5. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  6. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  7. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  8. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  9. A Study Of Vedolizumab In Children And Teenagers With Moderate To Severe Ulcerative Colitis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness, safety, pharmacokinetics (PK), and immune response of high and low doses in 3 ...

  10. A Study To Assess The Effectiveness And Safety Of UGN-102 As A Primary Chemoablation Agent In Patients With Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) At Intermediate Risk Of Recurrence - Mayo Clinic

    A Study To Assess The Effectiveness And Safety Of UGN-102 As A Primary Chemoablation Agent In Patients With Low Grade Non-Muscle-Invasive Bladder Cancer (LG ...